Ignite Creation Date:
2024-10-26 @ 3:43 PM
Last Modification Date:
2024-10-26 @ 3:43 PM
Study NCT ID:
NCT06653608
Status:
COMPLETED
Last Update Posted:
None
First Post:
2024-10-19
Brief Title:
Clinical Efficacy of Novel Jasminum-based Calcium Hydroxide Medicament
Sponsor:
None
Organization:
None
Study Overview
Official Title:
Clinical Efficacy of Novel Jasminum-based Nano-reinforced Calcium Hydroxide Medicament on Postoperative Endodontic Pain a Triple-blind Study
Status:
COMPLETED
Status Verified Date:
2024-10
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
No
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
A triple-blind parallel group randomized trial with an allocation ratio of 11 Participants randomly allocated into two groups A and B In group A nano-reinforced calcium hydroxide medicament was utilized while in group B calcium hydroxide medicament without nanoparticles was used Post-operative pain was assessed after 4 hours 24 hours 48 hours 72 hours 96 hours
Detailed Description:
This triple-blind parallel group randomized clinical trial was conducted at the department of Operative Dentistry and Endodontics School of Dentistry from April 24 2024 to September 25 2024 Participants were randomly distributed into two groups by Lottery method A consecutive non-probability sampling technique was used Before initiating treatment participants were briefed about the intervention and their preoperative pain score was recorded In both groups endodontic treatment was initiated under rubber dam isolation Access opening done and canals explored Working length taken by radiographic method and reconfirmed by an electronic apex locator Afterwards canals were prepared till Master Apical File size F2 4 Taper In group A Nano-reinforced calcium hydroxide medicament was placed while in group B calcium hydroxide without nanoparticles was utilized Participants were instructed to rate their postoperative pain record after 4hrs 24hrs 48hrs 72hrs and 96hrs
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None